UIH(SH:688271) Shang Hai Zheng Quan Bao·2025-04-08 23:26Core Viewpoint - Shanghai United Imaging Healthcare Co., Ltd. has achieved significant milestones in obtaining medical device registrations, enhancing its competitive edge in the global market [1][2]. Group 1: Company Achievements - As of the end of Q1 2025, the company has registered products in over 80 countries and regions globally, with more than 140 products approved for market launch [1]. - The company has received FDA certification for 49 products and CE certification for another 49 products, including the complete uMI Panorama series [1]. - The uMR Jupiter is noted as the only full-body clinical ultra-high-field MRI system globally with NMPA, FDA, and CE approvals [1]. Group 2: Product Development and Market Strategy - The company has launched strategic innovative products in 2024, including the uLinac HalosTx precision radiotherapy system, uMR Max next-generation 3.0T MRI, and uAngio AVIVA intelligent suspension DSA [1]. - The acquisition of medical device registrations is expected to diversify the company's product offerings and meet varied clinical needs, thereby strengthening its core competitiveness [2]. - The company is developing products tailored to the specific needs of different countries and regions, facilitating the expansion of its product types available for sale internationally [2].